News
Moderna stock has faced heavy pressure from negative headlines, regulatory setbacks and political uncertainty. See why I ...
Advertisement HHS cancels $590 million contract with Moderna for bird flu vaccine Plus, here's how mRNA vaccines like the one Moderna is developing work Beginning of dialog window.
Moderna Inc. said its experimental flu shot met its goal in a late-stage trial, clearing the path for its broader strategy of selling combination vaccines. The shot’s efficacy was 27 percent ...
The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...
The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.
According to the CDC, there has been a decline in animal infections and no reports of human cases since February.
HHS cancels $590 million contract with Moderna for bird flu vaccine Plus, here's how mRNA vaccines like the one Moderna is developing work ...
HHS cancels $590 million contract with Moderna for bird flu vaccine Plus, here's how mRNA vaccines like the one Moderna is developing work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results